Ike Swetlitz

CVS has withdrawn its guidance for this year and offered investors no outlook for the next amid struggles in both the pharmacy and insurance businesses. In September, CVS executives met with Glenview, which had accumulated a stake of about $700 million and was pushing for change.

(Bloomberg) -- CVS Health Corp. named Glenview Capital Management founder Larry Robbins to its board as part of an agreement with the activist firm that's been pressuring the company for change.

CVS Health Corp. named Glenview Capital Management founder Larry Robbins to its board as part of an agreement with the activist firm that's been pressuring the company for change.

Bausch + Lomb said it authorized management and advisers to explore a potential sale of the eye health company after shares dropped over reports of faltering deal talks with a group of private equity firms.

Hi, it’s Ike in Boston. Down in Washington, discussions about pharmacy benefit managers are heating up. More on that soon, but first ...

Eli Lilly & Co.’s weight-loss and diabetes drugs Mounjaro and Zepbound are no longer in short supply in the US, which means compounding pharmacies must stop making copycats in the coming months.

Hi, it’s Ike in Boston, where we’re getting barely more than 9 hours of sunlight on these short winter days. More on that soon, but first …

Sangamo Therapeutics Inc. fell as much as 67% in extended trading after Pfizer Inc. ended its partnership to develop a new gene therapy to treat hemophilia A.

Ike Swetlitz and Madison Muller 2 min read In This Article

Wegovy and Zepbound, the first-ever highly effective treatments for weight loss, were major advances. Why isn't progress faster?